Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.

Liang XN, Xie L, Cheng JW, Tan Z, Yao J, Liu Q, Su W, Qin X, Zhao JM.

Thromb Res. 2013 Aug;132(2):158-63. doi: 10.1016/j.thromres.2013.06.023. Epub 2013 Jul 13. Review.

PMID:
23856555
2.

Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.

Kim H, Cho C, Cho Y, Cho S, Yoon K, Kim K.

BMC Musculoskelet Disord. 2011 Jul 14;12:160. doi: 10.1186/1471-2474-12-160.

3.

Genetic polymorphisms in plasminogen activator inhibitor-1 predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese population.

Zhang Y, Wang R, Li S, Kong X, Wang Z, Chen W, Lin N.

Diagn Pathol. 2013 Oct 17;8:169. doi: 10.1186/1746-1596-8-169.

4.

The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.

Nie W, Li B, Xiu QY.

PLoS One. 2012;7(3):e34385. doi: 10.1371/journal.pone.0034385. Epub 2012 Mar 27.

5.

Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects.

Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T.

Transplantation. 2004 Jan 27;77(2):220-5.

PMID:
14742985
6.

Relation between osteonecrosis of the femoral head and PAI-1 4G/5G gene polymorphism: a meta-analysis.

Zeng Z, Wang B, Pan H.

Int J Clin Exp Med. 2015 Nov 15;8(11):20337-42. eCollection 2015.

7.

Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.

Lee YH, Song GG.

Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:8-14. doi: 10.1016/j.ejogrb.2013.12.030. Epub 2014 Jan 3. Review.

PMID:
24439532
8.

Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility: A case-control study.

Li Y, Liu FX, Yuan C, Meng L.

Medicine (Baltimore). 2017 Oct;96(42):e7047. doi: 10.1097/MD.0000000000007047.

9.

Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients.

Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP, Ganz R, Frey FJ, Kohler HP.

Transplantation. 2002 Oct 27;74(8):1147-52.

PMID:
12438962
10.

The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.

Zhang TT, Yuan L, Yang YM, Ren Y.

Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2326-31.

11.

Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.

Wang AY, Poon P, Lai FM, Yu L, Choi PC, Lui SF, Li PK.

Kidney Int. 2001 Apr;59(4):1520-8.

12.

Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.

Gong LL, Fang LH, Wang HY, Peng JH, Si K, Zhu J, Han FF, Wang YH, Du GH, Pei LX, Liu LH.

Steroids. 2013 Apr;78(4):401-8. doi: 10.1016/j.steroids.2013.01.004. Epub 2013 Jan 25.

PMID:
23357434
13.

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.

Wang J, Wang C, Chen N, Shu C, Guo X, He Y, Zhou Y.

Thromb Res. 2014 Dec;134(6):1241-8. doi: 10.1016/j.thromres.2014.09.035. Epub 2014 Oct 5.

PMID:
25450536
14.
15.

Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.

Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.

Prostate. 2007 Feb 1;67(2):172-7.

PMID:
17044080
16.

PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.

Xu K, Liu X, Yang F, Cui D, Shi Y, Shen C, Tang W, Yang T.

PLoS One. 2013 Nov 5;8(11):e79150. doi: 10.1371/journal.pone.0079150. eCollection 2013.

17.

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.

Thromb Res. 2012 Sep;130(3):e43-51. doi: 10.1016/j.thromres.2012.06.015. Epub 2012 Jul 6.

PMID:
22771216
18.

PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.

Wang S, Cao Q, Wang X, Li B, Tang M, Yuan W, Fang J, Qian J, Qin C, Zhang W.

PLoS One. 2013;8(2):e56797. doi: 10.1371/journal.pone.0056797. Epub 2013 Feb 20.

19.

No Association of SERPINE1 -675 Polymorphism With Sepsis Susceptibility: A Meta-Analysis.

Shi C, Sui Z, Li L, Yang R.

Medicine (Baltimore). 2015 Nov;94(45):e1173. doi: 10.1097/MD.0000000000001173. Review.

20.

Association of genetic variants of fibrinolytic system with stroke and stroke subtypes.

Babu MS, Prabha TS, Kaul S, Al-Hazzani A, Shafi G, Roy S, Balakrishna N, Jyothy A, Munshi A.

Gene. 2012 Mar 1;495(1):76-80. doi: 10.1016/j.gene.2011.12.046. Epub 2012 Jan 5.

PMID:
22240314

Supplemental Content

Support Center